HOME Research Insight Product Launches, Collaborations, Acquisitions, and Partnerships are the Key Strategies Adopted by Market Players in the Molecular Diagnostics Market



Product Launches, Collaborations, Acquisitions, and Partnerships are the Key Strategies Adopted by Market Players in the Molecular Diagnostics Market


The molecular diagnostics market is dominated by established players such as Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Abbott Laboratories (U.S.), Hologic Inc. (U.S.), and Grifols (Germany).

Roche Diagnostics held the top position in 2015 in the molecular diagnostics market. The company has retained its leading position in the global market through its broad range of innovative products. The Cobas series of instruments and reagents are the leading products in the market. The company has also strengthened its position through a blend of organic and inorganic strategies. Roche launched four products in the area of molecular diagnostics in the past three years. Moreover, the company acquired GeneWEAVE BioSciences, Inc. (U.S.) in 2015 and IQuum, Inc. (U.S.) in 2014. These acquisitions helped the company strengthen its point-of-care molecular diagnostics portfolio.

Roche Diagnostics was followed by QIAGEN N.V. with the second-largest share of the global market. QIAGEN has maintained its footprint in the market through the launch of innovative products. For instance, the company launched three molecular diagnostics tests in September 2015, namely, RespiFast RG Panel, careHPV Test, digene HC2 DNA Collection Device. Similarly, the company strengthened its position in the molecular diagnostics market through collaboration and partnership strategy. It is evident from QIAGEN’S collaboration with Seegene Inc. (South Korea) in June 2015. With this collaboration, QIAGEN leveraged the expertise of Seegene in multiplex real-time PCR analysis in a single reaction.

Product launches, collaborations, acquisitions, and partnerships are the preferred strategies adopted by key players in this market to enhance their product offerings, increase their market shares, cater to customers’ demands, and consolidate their market presence.

Developing markets in Asia-Pacific such as China, India, South Korea, Taiwan, and Singapore are also revenue pockets for market players, due to increasing investments in the healthcare industry and expansion of private-sector hospitals to rural areas in various APAC countries.

Related Reports:

Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User (Hospitals, Laboratory), Product & Service (Reagent, Software) - Forecast to 2021

Contact:
Mr.Rohan
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports